A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...
Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...
Dexcom (NSDQ:DXCM) announced today that it plans to launch its G7 15 Day continuous glucose monitor (CGM) in the U.S. next ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the Dexcom G7 15 Day Continuous Glucose ...
IT’S exciting times for Irish rugby with the modernisation of a nearly 100 year old stadium. In 2018 Connacht Rugby announced ...
In honor of National Diabetes Awareness Month, DAV (Disabled American Veterans) announced today a new strategic partnership ...
Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer.
A new store design, though, will be found at Winnipeg’s newest London Drugs location, opening on Nov. 21 in CF Polo Park. The ...
NorthernIrelandWorld on MSN
Diabetic friends following their dreams and living life to the full
To mark World Diabetes Day, Banbridge ‘besties’, Beth McDaniel and Ellen Watson, aka The Diabetic Duo, have shared their ...
Discover World Diabetes Day 2025 insights on rising US diabetes rates, Colorado stats, and game-changing tech like Dexcom G7 that eases daily management for millions.
Cloud firm Datadog was added to the S&P 500, instead of the larger Robinhood. The Navy’s F/A-XX advanced, sixth-generation fighter jet might not happen, according to a report, hammering shares of the ...
Looking back on patient monitoring stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback